Ontology highlight
ABSTRACT: Background
Identification of those at risk of more severe psoriasis and/or associated morbidities offers opportunity for early intervention, reduced disease burden and more cost-effective healthcare. Prognostic biomarkers of disease progression have thus been the focus of intense research, but none are part of routine practice.Objectives
To identify and catalogue candidate biomarkers of disease progression in psoriasis for the translational research community.Methods
A systematic search of CENTRAL, Embase, LILACS and MEDLINE was performed for relevant articles published between 1990 and December 2021. Eligibility criteria were studies involving patients with psoriasis (any age, n ≥ 50) reporting biomarkers associated with disease progression. The main outcomes were
SUBMITTER: Ramessur R
PROVIDER: S-EPMC9796834 | biostudies-literature | 2022 Oct
REPOSITORIES: biostudies-literature